Skip to main content
. 2015 May;7(3):153–169. doi: 10.1177/1758834015572343

Figure 1.

Figure 1.

Colon cancer biology: focus on epidermal growth factor (EGF) pathway and sensitivity to epidermal growth factor receptor (EGFR) monoclonal antibodies (MoAbs). (A) Frequency of KRAS, NRAS, and BRAF tumor genes mutations in patients with advanced colorectal cancer (CRC). (B) Role of tumor biology for the estimated sensitivity to EGFR MoAbs in metastatic CRC.